Are the generic drugs in your medicine cabinet safe and effective?
I had been on name-brand Wellbutrin XL for three years when my employer altered our prescription health care benefit plan so that if a generic drug is available, you must get it or pay the hefty difference out-of-pocket. In this case, that difference would be an additional $150 a month for name brand Wellbutrin. Alas, generic it is. I received my first batch of generic Wellbutrin last spring and immediately developed debilitating migraines each afternoon that made depression symptoms pale in comparison. My benefits plan is further structured so that I must use mail-order medication delivery. I don’t mind because the meds are often much cheaper than pharmacy co-pays, but you also have no control over which generic medication you will be sent. I’ve received several different generic Wellbutrin brands now and unlike their name-brand equivalent, all have some degree of unpleasant side effects.
I discussed these concerns with my doctor at our thrice-monthly appointment today and what she said surprised me – and maybe it will you, too.
Aren’t generic drugs the same?
A generic drug is a copy of a brand-name drug that ostensibly have exactly the same dosage, intended use, effects, side effects, route of administration, risks, safety and strength as the original drug. In other words, generic drugs are identical or bioequivalent to its brand name counterpart. The term “bioequivalent” makes you think the drugs are, well, equivalent, right? Not exactly.
The Food and Drug Administration requires the bioequivalence of generic products to be between 80 and 125 percent of that of the original drug. The agency determines bioequivalency with two tests. The first test determines whether a generic product is significantly less bioavailable than the brand name product. Bioavailability refers to the rate and extent of absorption of the test drug. The second test is basically an inverse of the first; it determines whether a brand name product is significantly less bioavailable when substituted for a generic product.
A difference in bioavailability of more than 20 percent in the first test is determined to be significant and will cause the generic drug to fail inspection. Likewise, since the second test measures the brand name drug, it cannot have more than a 25 percent deviance from the generic drug or the generic drug will fail – hence the 80-125 percent interval. If you’re wondering why the second number allows for greater deviance than the first, the original rule was supposed to be 80-120, but was changed to 80-125 to be symmetric on the log scale where most tests are conducted.
So, in non-geek speak, a generic drug can potentially be only 80 percent as effective as the brand name drug and still be considered bioequivalent. The FDA determines this 20 percent deviance to be statistically insignificant, but I’m not so sure. When taking birth control for instance, that 20 percent window looms awfully large. The FDA approved generic buproprion and insists it is bioequivalent to brand name drug Wellbutrin, but in a review conducted by the agency of generic buproprion manufactured by Teva versus the name brand Wellbutrin, even it concedes the prevalence of increased side effects and a loss of antidepressant affect in the generic version. That is, for the 150mg dosage. The FDA didn’t even test bioequivalency rates for 300mg dosages (which is the dosage I’m taking – how reassuring). Assuming that the 89 percent buproprion bioavailability rate at a 150mg dosage is similar for the 300mg dosage, that 11 percent deviance in effectiveness rate can mean a world of difference when you’re being treated for a psychiatric condition.
Pharmacies usually dispense generic as a rule unless otherwise requested and since prices fluctuate, you aren’t always guaranteed the same generic brand month-to-month. What this means is that you might take a generic drug one month that is 90 percent bioequivalent to the brand name and take another generic drug the next month that’s only 80 percent bioequivalent. Compounding this is the fact that when a company seeks FDA approval for a new generic, it must prove only that the active ingredient is the same. Each generic drug contains different inactive ingredients, fillers and formulations, which might cause treatment failures and also allergic reactions and side effects in drug-takers.
Other generic drugs problems:
Almost half of all prescriptions today in the U.S. are filled with generic drugs and according to my doctor, who is Indian, many generic drugs are now manufactured in China and India where quality control standards are far less stringent than in the U.S. Anyone remember the Chinese pet food scandal that caused the death of some 4,000 pets in the U.S.? You might also recall the massive Chinese toy recall or the more recent recall of tainted milk. In another scandal earlier this year, a dozen people died after developing a severe allergic reaction to the blood thinner heparin. The resulting investigation found that Chinese suppliers added a cheap, dangerous compound to the raw ingredient. The Chinese government passed a law last year to strengthen its drug regulatory agency, but the organization remains riddled with corruption nonetheless. Just how corrupt? Last year, the Chinese government executed the head of its drug agency for approving fake medicine in exchange for bribes kind of corrupt.
According to a Washington Post investigation last summer, generic products from India and China now dominate the generic and over-the-counter drug markets – India produces about 350 varieties and strengths of antidepressants, heart medicines, antibiotics and other drugs and last year China exported $675 million in pharmaceutical ingredients and products in the U.S. market. Yet the FDA conducted tests of only about 200 plants in those countries over a seven year period. By contrast, the agency made 1,222 inspections U.S. drug manufacturing plants last year alone.
My doctor appears well-informed about generic drugs, but not all doctors are. According to the American Heart Association, a 1997 questionnaire to assess attitudes, beliefs, knowledge and experiences with generic drugs and generic substitution was sent to 3,639 physicians nationwide. The report then focused on perceptions of the therapeutic index for 15 branded drugs and their generic substitutes. Only 17 percent of physicians could correctly identify the FDA standards for bioequivalency.
So, how do I make sure my generic drug is safe and effective?
Earlier this year the FDA asked for an extra $275 million to insure the safety of imported drugs and food, with a sizable portion of the money expected to be used to hire staff to inspect foreign drug plants. In the meantime, it’s virtually impossible for pharmacists or patients to identify the source of their medication, because there are no requirements for country-of-origin labeling of drugs and drug ingredients can pass through several countries before ending up on pharmacy shelves and in your medicine cabinet.
Consumerlab.com, an independent laboratory, tests supplements and medications but charges $29.95 a year for access to test data. The United States Pharmacopeia, another independent non-profit lab, sets the standards for all prescription and over-the-counter medication and other health care products recognized and used in 130 countries. USP issues a distinctive “USP Verified” mark to products that pass its stringent verification requirements. Participation is voluntary, but you might ask your pharmacist if the drug you receive is USP verified.
Not all generic drugs are less effective than name brand equivalents and considering the soaring costs of medication coupled with an economic recession, cheaper drugs may be the only option for many cash-strapped patients. It’s important to be to be vigilant of the medication brands you are taking. If you receive a different generic medication and it doesn’t seem to be working as well as the name brand or other generic version you took previously, take it back to the pharmacy or discuss alternate medication options with your doctor. If your prescription plan or personal finances mandate you buy generic and you find a generic that works well for you, ask your pharmacy for that specific generic brand on each refill. And if you prefer name brand, but your prescription plan provider won’t cover it without substantial cost to you, they may waive that extra fee with a letter of medical necessity from your doctor.
Anyone have similar experiences with generic drugs or have suggestions on how to make sure your drugs are safe and effective?








posted on November 14th, 2008 at 2:02 am
posted on November 14th, 2008 at 2:12 am
posted on November 14th, 2008 at 3:13 am
posted on November 14th, 2008 at 3:32 am
posted on November 14th, 2008 at 7:02 am
posted on November 14th, 2008 at 7:39 am
posted on November 14th, 2008 at 9:21 am
posted on November 14th, 2008 at 10:07 am
posted on November 14th, 2008 at 10:25 am
posted on November 14th, 2008 at 12:28 pm
posted on November 14th, 2008 at 1:38 pm
posted on November 14th, 2008 at 2:41 pm
posted on November 14th, 2008 at 2:49 pm
posted on November 14th, 2008 at 3:19 pm
posted on November 14th, 2008 at 3:52 pm
posted on November 14th, 2008 at 4:35 pm
posted on November 14th, 2008 at 5:23 pm
posted on November 15th, 2008 at 5:25 am
posted on November 16th, 2008 at 3:14 am
posted on November 16th, 2008 at 7:23 pm
posted on November 17th, 2008 at 11:33 am
posted on November 17th, 2008 at 1:07 pm
posted on November 23rd, 2008 at 9:58 am
posted on February 10th, 2009 at 12:56 pm